Skip to main content
. 2015 Aug 31;290(46):27460–27472. doi: 10.1074/jbc.M115.683706

TABLE 2.

Genes disrupted in mutants identified in the VPA-sensitivity screen (vma mutants are underlined)

Group Genes
1 Secretory pathway VMA3/CUP5, VPS67/VPS51, SAC2/VPS52, VPS53, LUV1/VPS54, SEC22, PEP12, STP22/VPS23, VPS25, BRO1/ VPS31, VPS66, VMA5, VMA21, VMA16/PPA1, VPH1, PMR1, MNN11, COG6, SAC1, BRE5, RVS167, RVS161,
2. Transcription complexes CCR4, TAF14, MOT2, POP2, SNF4
3. Ubiquitin-dependent proteolytic pathway MEP2, RPN4, DEF1, UBP3, BRE5,
4. Mitochondrial function AFG3, MGM101, MRPL27, MMT2, AIM13/MCS19
5. Transporters TRK1, CTR1, GUP1, HXT12, AQR1, TFP3, ATP15, RTC2, SPF1/COD1
6. Functionally unrelated (other) IRA1, NPL3, RMD7, SER2, PAC10, KAR3, NCL1, NPL6, BUB1, SPC72, MOG1, FYV6, SDL1, TRP1, NIS1, MKT1, CTK1, TRX3, RPL21A, ERF2, CAT2, GSH1, SLI15, NHP10, KEM1, SCS2, POC4, SLM4, EOS1, NCS2, KRE28, DCG1
7. Uncharacterized ORFs YIL090W, YCR061W, YJR018W, YIL166C, YNL120C, YML010W-A